Trastuzumab
- PDF / 141,021 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 48 Downloads / 155 Views
1
S
Cardiotoxicity: 26 case reports Twenty-six women with breast cancer developed cardiotoxicity during treatment with trastuzumab [ages not clearly stated; routes, dosages, durations of treatment to reactions onset and outcomes not stated]. Some of the women had a history of cardiovascular disease and/or obesity. Nineteen women with early breast cancer and six women with advanced breast cancer developed asymptomatic cardiotoxicity, defined as an absolute drop of at least 10% with a final left ventricular ejection fraction
Data Loading...
